The Market and Potential for Molecular Point of Care Diagnostics

LONDON, Dec. 17, 2016 /PRNewswire/ -- Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world.bThe Market and Potential for Molecular Point of Care Diagnostics examines the major segments of molecular POC diagnostics, exploring in-depth current sales and market opportunity and providing the following market information:

Molecular POC Market for Respiratory Tract Infections (2015-2020)
Molecular POC Market for Women's Health and Sexual Health (2015-2020)
Molecular POC Market for High-Burden Diseases (2015-2020)
Molecular POC Market for GI Pathogens, HAIs and Bloodstream Infections (2015-2020)
Molecular POC Market for Non-Infectious Diseases (2015-2020)
Investments in Decentralized Molecular Diagnostics Companies (2014-2015)
Potential Entrants into Molecular POC Diagnostics (Vendor, Current Platform[s], Primary Market for Platform, Assay Menu, Applicable Tech)

Clinical molecular diagnostics has steadily progressed from research-emergent, highly complex tests performed in few labs to analyzer-integrated and -automated steps from sample preparation through results analysis. The Market and Potential for Molecular Point of Care Diagnostics probes molecular point of care diagnostics developments and applications, including:


Selected Isothermal Amplification Methods and Platform Examples
Selected Analyzer Platforms for Decentralized and POC Molecular Testing with Image Sensor Detectors (CCD, CMOS)
Selected Analyzer Platforms for Decentralized and POC Molecular Testing with Photodiode Detectors
Selected Analyzer Platforms for Decentralized and POC Molecular Testing with Electrochemical Detectors
Selected Analyzer Platforms for Decentralized and POC Molecular Testing with Immunochromatographic Detection
Selected NGS Platforms for Decentralized and POC Sequencing
Market-Available Molecular POC Diagnostic Platforms (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test Principles)
Market-Available Hospital Molecular Diagnostic Platforms (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test Principles)
Hospital and POC Molecular Diagnostic Platforms in Development (Vendor, Assay Menu, Procedure Integration, Test Principles)
Market-Available Molecular Diagnostic Platforms for Emerging Markets and the Developing World (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test Principles)
Molecular Diagnostic Platforms in Development for Emerging Markets and the Developing World (Vendor, Assay Menu, Procedure Integration, Test Principles)
Line Probe Assays and Other Molecular Lateral Flow Test Strips (Vendor, Assay Menu, Planned Assays, Regulatory Status)
Potential Entrants into Molecular POC Diagnostics (Vendor, Current Platform[s], Primary Market for Platform, Assay Menu, Applicable Tech)
Selected Developmental Molecular POC-Enabling Technologies and Platforms by Vendor

Profiled companies include those with clinical molecular diagnostic systems applicable to POC testing markets; molecular diagnostic systems applicable to hospital lab molecular testing; development-stage molecular diagnostic systems for decentralized testing; molecular diagnostic products for use primarily in emerging markets of the developing world and for field testing; companies with original equipment manufacturer (OEM) platforms and component technologies that could be featured in the molecular POC diagnostics market; and other companies that have been involved in molecular POC diagnostics through investment, collaborative research or technology development that could allow them to enter the market. Companies profiled include:


Oxford Nanopore Technologies
Xagenic
T2 Biosystems
Rheonix
Nanosphere
Great Basin Scientific
DNA Electronics
Enigma Diagnostics
Curetis
Biocartis
Atlas Genetics

Download the full report: https://www.reportbuyer.com/product/2051940/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-market-and-potential-for-molecular-point-of-care-diagnostics-300380515.html

SOURCE ReportBuyer